Rodrigo Romero-Nava

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 11

Top Topics

Insulin Resistance

Pulmonary Arterial Hypertension

Top Venues

Current molecular pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Lourdes Nallely Acevedo-Villavicencio, Carlos Enrique López-Luna, Juan Castillo-Cruz, Rocío Alejandra Gutiérrez-Rojas, Iris Selene Paredes-González, Santiago Villafaña, Fengyang Huang, Cruz Vargas-de-León, Rodrigo Romero-Nava, Karla Aidee Aguayo-Cerón
Modulator Effect of AT1 Receptor Knockdown on THP-1 Macrophage Proinflammatory Activity. Biology 13 (6) (2024)
Adrián Hernández-DiazCouder, Rodrigo Romero-Nava, Blanca E Del Rio-Navarro, Fausto Sánchez-Muñoz, Carlos A Guzmán-Martín, Nayely Reyes-Noriega, Octavio Rodríguez-Cortés, José J Leija-Martínez, Juan Manuel Vélez-Reséndiz, Santiago Villafaña, Enrique Hong, Fengyang Huang
The Roles of MicroRNAs in Asthma and Emerging Insights into the Effects of Vitamin D 3 Supplementation. Nutrients 16 (3) (2024)
Adrián Hernández-DiazCouder, Rodrigo Romero-Nava, Blanca E Del Rio-Navarro, Fausto Sánchez-Muñoz, Carlos A Guzmán-Martín, Nayely Reyes-Noriega, Octavio Rodríguez-Cortés, José J Leija-Martínez, Juan Manuel Vélez-Reséndiz, Santiago Villafaña, Enrique Hong, Fengyang Huang
The Roles of MicroRNAs in Asthma and Emerging Insights into the Effects of Vitamin D 3 Supplementation. Nutrients 16 (3) (2024)
Iván Filiberto Contreras-Hernández, Cruz Vargas-de-León, Luis Rey García-Cortes, Adriana Flores-Miranda, Rodrigo Romero-Nava, María Esther Ocharán-Hernández
Comparison of Ten Surrogate Insulin Resistance and Obesity Markers to Identify Metabolic Syndrome in Mexican Adults. Metabolites 14 (7) (2024)
Adrián Hernández-DiazCouder, Rodrigo Romero-Nava, Blanca E Del Rio-Navarro, Fausto Sánchez-Muñoz, Carlos A Guzmán-Martín, Nayely Reyes-Noriega, Octavio Rodríguez-Cortés, José J Leija-Martínez, Juan Manuel Vélez-Reséndiz, Santiago Villafaña, Enrique Hong, Fengyang Huang
The Roles of MicroRNAs in Asthma and Emerging Insights into the Effects of Vitamin D 3 Supplementation. Nutrients 16 (3) (2024)
Adrián Hernández-DiazCouder, Rodrigo Romero-Nava, Blanca E Del Rio-Navarro, Fausto Sánchez-Muñoz, Carlos A Guzmán-Martín, Nayely Reyes-Noriega, Octavio Rodríguez-Cortés, José J Leija-Martínez, Juan Manuel Vélez-Reséndiz, Santiago Villafaña, Enrique Hong, Fengyang Huang
The Roles of MicroRNAs in Asthma and Emerging Insights into the Effects of Vitamin D 3 Supplementation. Nutrients 16 (3) (2024)
Lourdes Nallely Acevedo-Villavicencio, Carlos Enrique López-Luna, Juan Castillo-Cruz, Rocío Alejandra Gutiérrez-Rojas, Iris Selene Paredes-González, Santiago Villafaña, Fengyang Huang, Cruz Vargas-de-León, Rodrigo Romero-Nava, Karla Aidee Aguayo-Cerón
Modulator Effect of AT1 Receptor Knockdown on THP-1 Macrophage Proinflammatory Activity. Biology 13 (6) (2024)
Adrián Hernández-DiazCouder, Rodrigo Romero-Nava, Blanca E Del Rio-Navarro, Fausto Sánchez-Muñoz, Carlos A Guzmán-Martín, Nayely Reyes-Noriega, Octavio Rodríguez-Cortés, José J Leija-Martínez, Juan Manuel Vélez-Reséndiz, Santiago Villafaña, Enrique Hong, Fengyang Huang
The Roles of MicroRNAs in Asthma and Emerging Insights into the Effects of Vitamin D 3 Supplementation. Nutrients 16 (3) (2024)
Iván Filiberto Contreras-Hernández, Cruz Vargas-de-León, Luis Rey García-Cortes, Adriana Flores-Miranda, Rodrigo Romero-Nava, María Esther Ocharán-Hernández
Comparison of Ten Surrogate Insulin Resistance and Obesity Markers to Identify Metabolic Syndrome in Mexican Adults. Metabolites 14 (7) (2024)
Iván Filiberto Contreras-Hernández, Cruz Vargas-de-León, Luis Rey García-Cortes, Adriana Flores-Miranda, Rodrigo Romero-Nava, María Esther Ocharán-Hernández
Comparison of Ten Surrogate Insulin Resistance and Obesity Markers to Identify Metabolic Syndrome in Mexican Adults. Metabolites 14 (7) (2024)
Citlali Margarita Blancas-Napoles, Sandra Edith Cabrera-Becerra, Vivany Maydel Sierra-Sánchez, Sergio Adrian Ocampo-Ortega, Vanessa Giselle Garcia-Rubio, Rodrigo Romero-Nava, Fengyang Huang, Enrique Hong, Asdrúbal Aguilera-Méndez, Santiago Villafaña
siRNA Targeting ECE-1 Partially Reverses Pulmonary Arterial Hypertensionassociated Damage in a Monocrotaline Model. Current molecular pharmacology (2024)